Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine

Hum Psychopharmacol. 2004 Dec;19(8):585-6. doi: 10.1002/hup.644.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic Uptake Inhibitors / adverse effects*
  • Adrenergic Uptake Inhibitors / therapeutic use
  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Cyclopropanes / adverse effects*
  • Cyclopropanes / therapeutic use
  • Depressive Disorder / drug therapy*
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Milnacipran
  • Paroxetine / adverse effects
  • Paroxetine / therapeutic use
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Substance Withdrawal Syndrome / etiology*
  • Treatment Outcome

Substances

  • Adrenergic Uptake Inhibitors
  • Antidepressive Agents
  • Cyclopropanes
  • Serotonin Uptake Inhibitors
  • Paroxetine
  • Milnacipran